Pfizer Pharmaceutical Company: The World's Largest Pharmaceutical Company

EHS Guidelines

  GUIDELINE NAME OVERVIEW
0.0IntroductionExplains how the Pfizer EHS Guidelines relate to the overall Pfizer EHS management system, including procedures and documents; who must implement the Guidelines; the common structure used for each Guideline; and how the Guidelines operate as a whole.
Management Themes
1.0General EHS GuidelineDefines the basic elements to be included in all facility EHS programs: assessment; control; verification and testing; training and awareness; organization and documentation; roles and responsibilities; and management of change.
2.0ComplianceSets absolute compliance with host government legal requirements as the baseline of the Pfizer EHS management system, and clarifies Pfizer's long-standing system for assuring this level of performance.
3.0Management of Change for FacilitiesDefines the elements of the Pfizer program to evaluate and address the EHS implications of facility "Change," both for existing operations and for new or expanded facilities.
4.0Incident Preparedness and ResponseDefines the Pfizer standard for preventing, responding to, and investigating serious emergencies.
5.0Management Systems ReviewOutlines the evaluation to be undertaken to assure continuous improvement in EHS performance.
6.0InformationOutlines the Pfizer information reporting system needed to assure legal compliance, to improve sharing of good EHS programs and practices, to improve the understanding of the status of facility EHS programs, and to strengthen Pfizer's overall EHS performance.
Health & Safety
7.0Basic SafetyEstablishes the basic elements for a facility program to address general workplace risks.
8.0Fire Life SafetyEstablishes uniform requirements for fire life safety to assure that Pfizer colleagues have a consistent high-level of protection from the danger of workplace fires.
9.0Chemicals in the WorkplaceEstablishes a management system with minimum performance expectations necessary to avoid adverse health effects arising from workplace exposure to chemicals.
10.0Occupational Medical SupportDefines the Pfizer health and safety program elements to help prevent work-related illness and injury through proper placement and medical screening and to manage work-related illness and injuries to reduce frequency and severity.
11.0Process SafetyDefines the Pfizer health and safety program elements to prevent acute catastrophic events, such as accidental chemical releases, fires, explosions or unexpected process upsets from strong exothermic reactions or the release of large volumes of gas.
25.0Biological Agents in the WorkplaceDefines the requirements of a biological safety management system that must be implemented in order to avoid adverse health effects associated with working with biological hazards.
26.0Ionizing Agents in the WorkplaceDefines the requirements of a management system that must be implemented in order to avoid adverse health effects and harm to the environment associated with working with ionizing radiation hazards.
Environment
12.0Resource Conservation OverviewDescribes performance expectations and a common management approach to resource conservation that is detailed in Guidelines 13, 14, 15, 16, and 17.
13.0Release ReductionDefines a systematic approach to reduce releases of potentially hazardous substances.
14.0Waste MinimizationEstablishes a framework for the efficient use of resources, reducing the environmental impact of Pfizer operations and achieving cost savings.
15.0Water ConservationEstablishes a framework that promotes water conservation to preserve this finite resource and respond to Community expectations.
16.0Energy Conservation Defines the Pfizer program elements to minimize the use of fossil fuels, which are a non-renewable and limited natural resource, and, in the process, reduce Greenhouse Gas emissions related to facility activities.
17.0Environmentally Responsive PackagingDescribes Pfizer's approach to ensure that environmental considerations are integrated into the product packaging design process in order to conserve natural resources and minimize potential environmental impacts associated with the use and disposal of Pfizer product packaging.
18.0Ozone Depleting Compound ManagementDefines Pfizer program requirements to eliminate all Ozone Depleting Compound releases from facility operations.
19.0Waste ManagementDefines Pfizer program requirements to manage all waste streams to avoid negative impacts on human health, the environment, or Pfizer.
20.0Ground & Surface Water ProtectionDefines the Pfizer program requirements to protect ground and surface water by preventing releases and by remediating contaminated areas to minimize adverse EHS impacts.
External Affairs
21.0Community OutreachDefines the Pfizer program requirements to promote constructive relationships between Pfizer facilities and their local Communities, making the Communities better places to live and work while building public understanding and trust.
22.0Acquisition and Divestiture of Real PropertyEstablishes Pfizer program requirements for due diligence assessments prior to the acquisition or divestiture of any real property.
23.0Post-Manufacturing Product Risk Defines the Pfizer program requirements to ensure that post-manufacturing EHS risks of all new Pfizer-developed or in-licensed products are evaluated and addressed prior to product launch.
24.0Management of Contract Manufacturing and Research Defines the Pfizer program for ensuring that certain off-site manufacturing and research operations have sufficient resources and systems to protect their employees, the environment, and public health, while minimizing the risk of business interruption or liability to Pfizer.
Looking for a Pfizer Product?
A B-D E-H
I-N O-P R-Z
A-B C D-E
F-L M-P R-U V-Z
EHS Programs and Performance

Learn more about our specific EHS goals, programs and performance.